It is known that RBP1 is downregulated in several cancers, and an explanation has been proposed based on the fact that RBP1 inhibits the PI3K/Akt survival pathway [27], therefore downregulation of RBP1 promotes derepression of PI3K/Akt signalling and inhibits apoptosis of malignant cells. Here, AKT1 is linked to cancer.